Detalles de la búsqueda
1.
Different treatment strategies versus a common standard arm (CSA) in patients with newly diagnosed AML over the age of 60 years: a randomized German inter-group study.
Ann Hematol
; 102(3): 547-561, 2023 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-36695874
2.
Imatinib dose reduction in major molecular response of chronic myeloid leukemia: results from the German Chronic Myeloid Leukemia-Study IV.
Haematologica
; 104(5): 955-962, 2019 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-30514803
3.
Impact of unbalanced minor route versus major route karyotypes at diagnosis on prognosis of CML.
Ann Hematol
; 94(12): 2015-24, 2015 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-26385387
4.
Bendamustine compared to fludarabine as second-line treatment in chronic lymphocytic leukemia.
Ann Hematol
; 92(5): 653-60, 2013 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-23340738
5.
Six versus eight cycles of bi-weekly CHOP-14 with or without rituximab in elderly patients with aggressive CD20+ B-cell lymphomas: a randomised controlled trial (RICOVER-60).
Lancet Oncol
; 9(2): 105-16, 2008 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-18226581
6.
Lymphocyte-rich classical Hodgkin's lymphoma: clinical presentation and treatment outcome in 100 patients treated within German Hodgkin's Study Group trials.
J Clin Oncol
; 23(24): 5739-45, 2005 Aug 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-16009944
7.
Morphologic dysplasia in de novo acute myeloid leukemia (AML) is related to unfavorable cytogenetics but has no independent prognostic relevance under the conditions of intensive induction therapy: results of a multiparameter analysis from the German AML Cooperative Group studies.
J Clin Oncol
; 21(2): 256-65, 2003 Jan 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-12525517
8.
Treatment of older patients with AML.
Crit Rev Oncol Hematol
; 56(2): 247-59, 2005 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-16246568
9.
Bone marrow mastocytosis associated with IgM kappa plasma cell myeloma.
Leuk Lymphoma
; 45(4): 801-5, 2004 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-15160959
10.
Acute myeloid leukemia: treatment over 60.
Rev Clin Exp Hematol
; 6(1): 46-59; discussion 86-7, 2002 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-12060483
11.
Tolerability-adapted imatinib 800 mg/d versus 400 mg/d versus 400 mg/d plus interferon-α in newly diagnosed chronic myeloid leukemia.
J Clin Oncol
; 29(12): 1634-42, 2011 Apr 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-21422420
12.
Imatinib combined with mitoxantrone/etoposide and cytarabine is an effective induction therapy for patients with chronic myeloid leukemia in myeloid blast crisis.
Cancer
; 109(8): 1543-9, 2007 Apr 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-17340589
13.
Weekly infusional high-dose fluorouracil (HD-FU), HD-FU plus folinic acid (HD-FU/FA), or HD-FU/FA plus biweekly cisplatin in advanced gastric cancer: randomized phase II trial 40953 of the European Organisation for Research and Treatment of Cancer Gastrointestinal Group and the Arbeitsgemeinschaft Internistische Onkologie.
J Clin Oncol
; 25(18): 2580-5, 2007 Jun 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-17577037
14.
Double induction containing either two courses or one course of high-dose cytarabine plus mitoxantrone and postremission therapy by either autologous stem-cell transplantation or by prolonged maintenance for acute myeloid leukemia.
J Clin Oncol
; 24(16): 2480-9, 2006 Jun 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-16735702
Resultados
1 -
14
de 14
1
Próxima >
>>